A major obstacle to the mapping of genotype-phenotype relationships is pleiotropy, the tendency of mutations to affect seemingly unrelated traits. Pleiotropy has major implications for evolution, development, ageing, and disease. Except for disease data, pleiotropy is almost exclusively estimated from full gene knockouts. However, most deleterious alleles segregating in natural populations do not fully abolish gene function, and the degree to which a polymorphism reduces protein function may influence the number of traits it affects. Utilizing genome-scale metabolic models for Escherichia coli and the baker's yeast Saccharomyces cerevisiae, we show that most fitness-reducing full gene knockouts of metabolic genes have pleiotropic effects, i.e., they compromise the production of multiple biomass components.
Abstract
A major obstacle to the mapping of genotype-phenotype relationships is pleiotropy, the tendency of mutations to affect seemingly unrelated traits. Pleiotropy has major implications for evolution, development, ageing, and disease. Except for disease data, pleiotropy is almost exclusively estimated from full gene knockouts. However, most deleterious alleles segregating in natural populations do not fully abolish gene function, and the degree to which a polymorphism reduces protein function may influence the number of traits it affects. Utilizing genome-scale metabolic models for Escherichia coli and the baker's yeast Saccharomyces cerevisiae, we show that most fitness-reducing full gene knockouts of metabolic genes have pleiotropic effects, i.e., they compromise the production of multiple biomass components.
Alleles of the same gene with increasingly reduced enzyme function typically affect an increasing number of biomass components. This increasing pleiotropy is often mediated through effects on the generation of currency metabolites such as ATP or NADPH. We conclude that the physiological effects observed in full gene knockouts will in most cases not be representative for alleles with only partially reduced enzyme capacity or expression level.
Introduction
A gene is pleiotropic if it affects more than one phenotypic trait (1, 2) . A classic example is phenylketonuria, a human disease that is caused by a single gene defect but which affects multiple systems, with symptoms ranging from lighter skin color to mental disorders (3).
Pleiotropic effects can cause alleles to affect fitness differentially at different ages, a phenomenon believed to be a major cause of aging (4-6); indeed, alleles contributing to increased longevity often show reduced fertility and stress tolerance (e.g., (7)). Similar antagonistic epistasis may underlie other important biological phenomena such as speciation (8) and cooperation (9) . Understanding the factors that contribute to pleiotropy is of fundamental importance in genetics (10) (11) (12) , evolution (13) (14) (15) (16) , development (17, 18) , as well as in disease (19, 20) and ageing (4) . In comparison to its fundamental importance, empirical knowledge of the prevalence and especially on the causal mechanisms of pleiotropy is scarce (2, 21) .
Experimental studies generally assess pleiotropy through the analysis of gene knockouts (22) (23) (24) . The degree of pleiotropy is then defined as the number of traits affected when a gene becomes fully non-functional. Wang et al. (24) analyzed phenotypes of large numbers of yeast, nematode, and mouse mutants. They found that pleiotropy is widespread: on average, yeast gene knockouts affect 8% of the examined traits; for the nematode, the corresponding number is 10%, for the mouse 3% (see also (23) ). The distributions of the degree of pleiotropy appear rather similar across very different study systems, from the skeletal features of mice (24) to metabolic systems (25) (26) (27) . Moreover, pleiotropy was found to be modular, such that sets of genes tend to affect the same sets of traits (24) .
In E. coli, 36% of metabolic reactions are catalyzed by enzymes also involved in other reactions; the same is true for 27% of metabolic reactions in the yeast Saccharomyces cerevisiae (27) . Pleiotropic effects of mutations that affect enzyme activity can be simulated from genome-scale metabolic models using constraint-based modeling techniques such as flux balance analysis (FBA) (28, 29) . The functional pleiotropy of a metabolic gene can then be defined as the number of biomass components whose maximal production is affected by the gene's knockout (25) . Previous studies using this definition found that a metabolic gene's functional pleiotropy is related to its propensity to form negative epistatic interactions with other metabolic genes (25, 26) .
While full gene knockouts are easily examined experimentally, they may not be representative of the effects of deleterious alleles segregating in natural populations: individual mutations may affect only a subset of all traits influenced by the gene (30) . Thus, it is important to distinguish between the pleiotropy of the gene and the pleiotropy of individual mutations, especially in evolutionary and clinical contexts. For example, while 4.6% of human SNPs implicated in complex non-Mendelian phenotypes show pleiotropic effects, most of these do not fully abolish protein function (31) . Experimental studies indicate that mutational pleiotropy tends to be smaller than gene pleiotropy (30) .
Genome-scale metabolic models allow us to dissect the relationship between gene and mutational pleiotropy in quantitative detail, without being hampered by the detection limits of experimental assays. Does the degree of pleiotropy depend on how severely a given allele of a metabolic gene reduces protein activity, i.e., are the same number of functions affected when protein function or expression is reduced only partially? To what extent is pleiotropy mediated through currency metabolites, such as ATP and NADPH, where a reduced production capacity may affect large numbers of otherwise unrelated processes? How modular is metabolic pleiotropy? Below, we address these questions by analyzing the metabolic networks of a representative bacterial model system, Escherichia coli, and a corresponding eukaryotic system, the baker's yeast Saccharomyces cerevisiae. We find that most gene knockouts that impact fitness do so by affecting the production of multiple biomass components, and that the number of affected biomass components typically increases with increasing mutation severity.
Pleiotropy is rarely a consequence of multiple molecular gene functions, but is an emergent property of the metabolic network; for many genes, pleiotropy is mediated through their involvement in the generation of currency metabolites.
Results and Discussion
Estimating pleiotropy from contributions to biomass components within the wildtype flux distribution
We first estimated wildtype flux distributions in the default growth condition for the genomescale metabolic model of E. coli (32) and the yeast S. cerevisiae (33) (obtained from https://sourceforge.net/projects/yeast/files/). The maximal biomass production rates were estimated using flux balance analysis (FBA) (28, 29) . For both model systems, we identified the flux distribution compatible with maximal biomass production that had the smallest sum of absolute fluxes, a strategy often termed parsimonious FBA (pFBA), which approximates optimal utilization of limited cellular protein resources (34) .
To simulate mutations that cause different reductions of protein function or expression and correspond to different deleterious alleles of a metabolic gene, we restricted the maximal flux through all reactions requiring this gene to a fixed percentage of the estimated wildtype flux (35) , starting from 100% (the wildtype) down to 0% (a full gene knockout) in steps of 0.5%. For each flux reduction, we defined the degree of pleiotropy (referred to simply as "pleiotropy" below) as the number of biomass components whose production was reduced compared to the maximal (wildtype) production. Note that with this definition, only genes with pleiotropy ≥2 are pleiotropic, while genes with pleiotropy 0 (no affected biomass component) or pleiotropy 1 (one affected biomass component) are non-pleiotropic.
Flux distributions at maximal biomass production rate are usually not unique (34) , and so in many cases a flux restriction through one reaction may be compensated by a rerouting of fluxes through alternative pathways. However, such rerouting would require the upregulation of the corresponding genes, which is unlikely to occur spontaneously (36) . More importantly, if we are interested in the de facto contribution of a given gene to the production of biomass components, then it is of no consequence if alternative pathways could take over part of this functionality. Thus, when calculating the maximal (wildtype) production rate of individual biomass components as well as when simulating the effects of mutations to a given metabolic gene, we did not allow the redistribution of fluxes to alternative pathways: we allowed only decreases, not increases, of any fluxes compared to the wildtype flux distribution obtained with pFBA.
Many genes affect the production of multiple biomass components
Pleiotropy varies widely between different genes. Mutations to the majority of genes affect no biomass components in the minimal growth medium assayed, independent of mutation severity (E. coli: 78.13% of genes; S. cerevisiae: 75.58%). Among genes contributing to biomass production-and thus fitness-in the wildtype, non-pleiotropic cases are rare: in E. Table 1 ).
These percentages reflect functional pleiotropy, the de facto contribution of gene products to biomass component production. If, instead, we are interested in the phenotypic effects of gene knockouts after allowing the mutant strain to adapt its physiology to its altered gene content, we must allow free redistributions of fluxes after the gene knockouts. Corresponding simulations show that genes with fitness contributions are, on average, essential for the production of 9.2% of E. coli biomass components and of 26.6% of S. cerevisiae biomass components after adaptation (Table 1 , Supplementary Figure S1 ). The degree of gene pleiotropy for yeast is higher than previous experimental estimates, which range from 2%-11% depending on the considered traits (24); however, experimental estimates of gene pleiotropy tend be downwardly biased due to experimental detection limits (2, 37) .
Pleiotropy is an emergent property of the metabolic network
Pleiotropy can be classified by its origin into type I pleiotropy, caused by multiple molecular functions of a gene product, and type II pleiotropy, caused by multiple physiological consequences of a single molecular function (2) . Similar distinctions have been made previously using the terms "horizontal" vs. "vertical" (10) and "mosaic" vs. "relational" (38) pleiotropy. Our model allows us to quantify the relative contributions of these two pleiotropy types. 41 This pattern is typical: the maximal pleiotropy arising from blocking only a single out of several reactions catalyzed by the same protein accounts for over 97% of the gene pleiotropy (E. coli 97.4%, yeast 97.6%). These numbers drop only marginally when we consider only gene products that are essential for multiple reactions, to 92.2% in E. coli and to 94.5% in yeast (Supplementary Figure S3) . We conclude that the vast majority of metabolic epistasis is of type II, i.e., is an emergent property of the metabolic network rather than a consequence of multiple molecular functions. This finding is consistent with the previous observation that the degree of pleiotropy in yeast is not significantly correlated with the number of molecular gene functions (39) .
Metabolic networks show significant but low modularity
The relationship between genes and biomass components (traits) can be represented as a bipartite graph, with links connecting genes with affected biomass components. Modules are defined as sets of genes and traits with significantly more within-module than between-module links (24) . Supplementary Figure S4 shows heatmaps that illustrate the modularity of both metabolic pleiotropy networks. To quantitatively assess the modularity, we used the LP&BRIM algorithm (40) , resulting in raw modularities of Q=0.235 for E. coli and Q=0.197 for S.
cerevisiae. Both networks show highly statistically significant modularity: in each case, the modularity of 10,000 randomly rewired networks was always lower that observed for the real pleiotropy network (i.e., P<0.0001; Supplementary Figure S5 ).
Following Ref. (24), we then defined the scaled modularity as the difference between the observed modularity and the mean modularity of randomly rewired networks, measured in number of standard deviations (41) . The E. coli pleiotropy network exhibits a scaled modularity of 9.1, while the S. cerevisiae network has a scaled modularity of 4.9, i.e., the modularity of metabolic pleiotropy is about 9 and 5 standard deviations higher than for corresponding random gene-trait networks. These values are surprisingly low: for five different experimental study systems and trait definitions, Wang et al. found a median scaled modularity of 37 (range 34-238).
Pleiotropy typically increases with increasing mutation severity
We next examined the pleiotropy of alleles with small-effect mutations, i.e., mutations that reduce enzyme capacity without fully abolishing enzyme function. About 20% of E. coli genes with fitness contributions have constant pleiotropy: small-effect mutations of these genes affect the same number of biomass components as full gene knockouts. In comparison, only 7.7% of yeast genes contributing to fitness exhibit constant pleiotropy.
All other genes contributing to fitness affect an increasing number of biomass components for increasingly deleterious alleles. Figure 2 shows this stepwise increase in pleiotropy for the example of Lipoamide dehydrogenase (gene names: E. coli b0116, S. cerevisiae YFL018C;
for additional examples, see Supplementary Figure S6 . In both organisms, pleiotropy typically increases in about a dozen steps from weakly to strongly deleterious alleles (Figure 3 ; mean number of steps: E. coli 11.6, S. cerevisiae 12.6).
The pleiotropy of the full gene knockout constitutes an upper limit to the number of stepwise increases in pleiotropy. However, the correlation between the number of steps and pleiotropy at full knockout was even stronger than expected from this relationship (Supplementary Figure   S7 , Spearman's ρ=0.926 (E. coli) and ρ= 0.986 (S. cerevisiae), P<10
-15 in each case). Thus, genes whose full knockout showed higher metabolic pleiotropy also showed more stepwise increases in pleiotropy for increasingly debilitating mutations.
All genes whose mutations affect the production of at least one biomass component must also affect the overall production of biomass (i.e., in the common interpretation of FBA, fitness).
The reverse is not true: a mutation to a gene may affect the maximal production of biomass, but not the production of any individual biomass component. This is a consequence of the algorithm employed to estimate production capabilities for individual biomass components. If we maximize the production of a single compound, then pathways usually concerned with the production of other biomass components can be diverted to the production of this compound.
While we find no such genes for S. cerevisiae, this is indeed the case for 3 essential E. coli genes, which encode transporters for acetate (b4067), magnesium/nickel/cobalt (b3816), and calcium/sodium (b3196, an antiporter).
The pleiotropy of most genes is mediated by currency metabolites
We can conceptually partition internal metabolites into currency metabolites-those involved in many reactions, e.g., to provide energy or redox equivalents (42)-and primary metabolites.
A deleterious allele may affect the production of a given biomass component because the Figure S8) .
Conclusion
Using constraint-based simulations of the metabolic models for E. coli and the yeast S.
cerevisiae, we have characterized the distributions of pleiotropy. Consistent with earlier computational (25) (26) (27) and experimental (22-24) studies, we found that the knockout of a majority of genes that contribute to fitness has pleiotropic effects. The vast majority of this gene pleiotropy is not caused by multiple molecular functions of the gene product (type I), but is an emergent property of the metabolic network (type II). Pleiotropy is modular, but to a lower degree than estimated experimentally for non-metabolic systems (24) .
For most pleiotropic genes, pleiotropy increases strongly for alleles with increasingly debilitating effects. Thus, standard measures of pleiotropy based on gene knockout studies are more likely to reflect the maximal degree of mutational pleiotropy of a given gene (2, 30) .
Alleles that only knock down protein activity (by reducing enzyme/transporter function or expression level) often affect only a subset of phenotypic traits, with additional traits affected progressively as alleles become more deleterious. Thus, the physiological effect of the full gene knockout will in most cases not be representative for the effects of deleterious alleles that retain some level of enzyme function. This type of effect is also evident from individual medical observations of pleiotropy. For example, some small-effect mutations affecting human SOX9 expression lead to minor skeletal malformations, while the consequences of large-effect mutations can include sex reversals (43) .
How can we understand the dependence of pleiotropy on the degree to which an allele reduces protein activity? For increasingly deleterious alleles, more and more metabolic resources must be channeled into the compensation of the compromised pathway; as a consequence of this increasing drain of resources, more and more other pathways are affected. Perhaps not surprisingly (26), we found that the pleiotropy of many genes is mediated through the generation of currency metabolites such as ATP, NADPH, or FADH 2. This is true for more than half of the pleiotropic genes in E. coli, and for 87% of pleiotropic genes in yeast.
Pleiotropy is a complex phenomenon: it is not constant, but varies between different alleles of the same gene, and its causes are often indirect. Thus, experimental as well as computational analyses of pleiotropy should move away from focusing on full gene knockouts, and instead consider explicitly the degree to which mutations reduce protein activity. The necessity of a corresponding nuanced view of pleiotropy may be particularly evident in studies of medically relevant mutations, where full knockouts are often lethal, while small-effect mutations may segregate at appreciable frequencies in the human population (44).
Materials and methods

Metabolic models
To simulate Escherichia coli metabolism, we used the metabolic reconstruction iJO1366 (32), encompassing 1,366 metabolic genes associated with 2,251 reactions. For the yeast S.
cerevisiae, we used the yeast7.6 model (https://sourceforge.net/projects/yeast) (33), accounting for 909 metabolic genes associated with 3,326 reactions.
The models specify growth reactions with 50 essential biomass components in E. coli Table S1 ) and 35 essential biomass components in S. cerevisiae (Supplementary Table S2 ), excluding inorganic ions, H2O, and products of the biomass reaction.
Flux distribution constraints derived from wildtype simulations
In order to approximate the de facto contribution of individual metabolic proteins to the production of individual biomass components in vivo, we should only consider flux distributions that are contained within realistic flux distributions -i.e., we should only use reactions that are naturally active during growth (biomass production) in the nutritional environment studied, and fluxes should not exceed these wildtype fluxes. We thus first estimate the wildtype flux 
Estimating pleiotropy
For each essential biomass component, we added a new exchange reaction representing its secretion (45) . As some biomass components may be coupled through the biomass reaction,
we allowed the excretion of all other biomass components when maximizing the production of one selected biomass component.
We then calculated the maximum production of each biomass component by maximizing its exchange reaction while enforcing the wildtype flux distribution constraints (Eq. 1). For each metabolic gene, we compared this unperturbed production with the maximal production rate of alleles with increasingly reduced protein activity, simulated by restricting the flux through all reactions catalyzed by the gene to a fixed fraction of the wildtype flux (35), which we reduced from 100% to 0% in steps of 0.5%.
We defined pleiotropy as the number of biomass components whose maximal production was reduced compared to the unperturbed state for the allele considered. Thus, an allele not involved in the maximal production of any essential biomass component is considered to have pleiotropy 0; an allele that affects the production of exactly one essential biomass component has pleiotropy 1.
Our estimate of pleiotropy reflects the actual contribution of a gene product to biomass formation, based on estimated enzyme and transporter activities in the wildtype. If instead, one is interested in a quantitative measure of essentiality, defined as the number of biomass components affected by a deleterious allele after the mutant strain has been allowed to adapt its physiology to the gene deletion, a different algorithm is more appropriate. In this case, one needs to allow the free redistribution of fluxes after the simulated activity reduction of the protein encoded by the gene in question. Note that experimental studies often employ a pragmatic working definition of pleiotropy that lies somewhere between the definitions of pleiotropy and quantitative essentiality proposed here: in these studies, pleiotropy is typically estimated as the number of traits with observable phenotypic changes after the gene knockout, but before allowing the strain to adapt. In this case, some fluxes may be rerouted due to enzymes and transporters that are expressed either spuriously or because of other roles they play in wildtype physiology, while other fluxes that require the upregulation of the corresponding enzymes and transporters will not yet be active.
Currency metabolites
In additional analyses, we made several cofactors freely available to study how pleiotropy is associated with the generation of currency metabolites. We did this by adding a balanced biochemical reaction that interconverts the activated and inactivated versions of the cofactor and allowing unlimited flux of this reaction in both directions. For example, to simulate free NADPH, we added the following reversible reaction: 
Software used
All simulations were performed in R (47) using sybil, a computer library optimized for efficient constraint-based modeling of metabolic networks (48) . We used IBM ILOG CPLEX as the linear solver, connected to sybil via the cplexAPI R package.
To calculate network modularities, we used the LP&BRIM algorithm (Label Propagation with Bipartite Recursively Induced Modules) implemented in Matlab (40) . 1 In the FBA calculations, fluxes are either constrained to not exceed the wildtype (WT) fluxes to estimate the de facto contribution of gene products to biomass production (pleiotropy), or they are allowed to vary freely to ass the number of biomass components for which gene products are essential even after allowing the mutant strain to adapt. 2 Solution when allowing unlimited conversion of NADPH to NADP+ 3 Mean (median) number of affected biomass components
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